Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Serum Sclerostin Levels in Cholesteatoma Patients

NCT03954288 is registered in ClinicalTrials.gov with Abant Izzet Baysal University as lead sponsor.

NCT NCT03954288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03954288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Serum Sclerostin Levels in Cholesteatoma Patients
Lead sponsor
Abant Izzet Baysal University
Phase
Observational
Overall status
Unknown status
Start date
March 29, 2019
Completion date
March 15, 2020
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholesteatoma, otitis media chronic